KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bausch Health Companies (BHC) Return on Sales (2016 - 2025)

Bausch Health Companies' Return on Sales history spans 17 years, with the latest figure at 0.04% for Q4 2025.

  • For Q4 2025, Return on Sales fell 8.0% year-over-year to 0.04%; the TTM value through Dec 2025 reached 0.01%, up 2.0%, while the annual FY2025 figure was 0.01%, 2.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.04% at Bausch Health Companies, down from 0.07% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.2% in Q3 2022 and bottomed at 0.3% in Q1 2021.
  • The 5-year median for Return on Sales is 0.04% (2022), against an average of 0.04%.
  • The largest annual shift saw Return on Sales rose 27bps in 2022 before it tumbled -37bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 0.01% in 2021, then crashed by -1980bps to 0.19% in 2022, then skyrocketed by 90bps to 0.02% in 2023, then soared by 296bps to 0.04% in 2024, then plummeted by -196bps to 0.04% in 2025.
  • Per Business Quant, the three most recent readings for BHC's Return on Sales are 0.04% (Q4 2025), 0.07% (Q3 2025), and 0.05% (Q2 2025).